Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients.
Clancy K, Hamill CS, O'Neill WQ, Vu B, Thuener J, Gui S, Li S, Fowler N, Rezaee R, Lavertu P, Wasman J, Patel M, Shaikh H, Vick E, Madabhushi A, Wise-Draper TM, Burkitt K, Teknos TN, Pan Q.
Clancy K, et al.
Cancers (Basel). 2021 Sep 28;13(19):4861. doi: 10.3390/cancers13194861.
Cancers (Basel). 2021.
PMID: 34638345
Free PMC article.